NCT01573754View on ClinicalTrials.gov

Hydroxychloroquine and Phlebotomy for Treating Porphyria Cutanea Tarda

PHASE2CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

March 21, 2006

Primary Completion Date

July 6, 2021

Study Completion Date

July 6, 2021

Conditions
Porphyria Cutanea Tarda
Interventions
DRUG

Hydroxychloroquine

100 mg by mouth twice weekly

PROCEDURE

Phlebotomy

450 mL every 2 weeks

Trial Locations (1)

77555

University of Texas Medical Branch, Galveston

All Listed Sponsors
lead

The University of Texas Medical Branch, Galveston

OTHER

NCT01573754 - Hydroxychloroquine and Phlebotomy for Treating Porphyria Cutanea Tarda | Biotech Hunter | Biotech Hunter